Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of prolactinomas.

Anna Spada1, Giovanna Mantovani, Andrea Lania

  • 1Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, University of Milan, 20122, Milano, Italy.

Pituitary
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Glucagon-stimulated copeptin response in children: a proof-of-concept study.

Frontiers in endocrinology·2026
Same author

Characterization of SF3B1 role in prolactin-secreting pituitary tumors.

Endocrine-related cancer·2026
Same author

Correction: Transition Care for Young People with Rare Bone and Mineral Conditions: A Scoping Review.

Advances in therapy·2026
Same author

Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems.

Clinical therapeutics·2026
Same author

Prevalence of somatic SF3B1R625H mutation in lactotroph tumours from a multi-centric cohort: a digital PCR-based study.

European journal of endocrinology·2026

Pituitary adenomas are typically monoclonal, but prolactinomas rarely show genetic mutations. Research is limited due to infrequent surgical removal, especially for typical, slow-growing tumors.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Human pituitary adenomas are monoclonal, suggesting neoplasia arises from single mutated cells.
  • Growth advantage in tumors is linked to proto-oncogene activation or tumor suppressor gene inactivation.
  • Prolactinomas, a type of pituitary adenoma, have shown a lack of detected mutational changes, with one exception of a lethal RAS mutation.

Purpose of the Study:

  • To investigate the limited understanding of molecular events in lactotroph proliferation.
  • To explore genetic and expression changes in prolactinomas.
  • To differentiate molecular abnormalities in typical versus aggressive prolactinomas.

Main Methods:

  • Review of existing literature on pituitary adenoma genetics and molecular biology.

Related Experiment Videos

  • Analysis of reported mutations and gene expression levels in prolactinomas.
  • Comparison of molecular findings between typical and aggressive prolactinoma subtypes.

    • Main Results:

    • No significant mutational changes have been identified in prolactinomas, except for a single aggressive case.
    • Modifications in oncogene and tumor suppressor gene expression levels are observed, but their causative role is unclear.
    • Molecular abnormalities are primarily described in aggressive, atypical prolactinomas, not typical ones.

    Conclusions:

    • The molecular basis of lactotroph proliferation, particularly in typical prolactinomas, remains poorly understood.
    • Genetic alterations are infrequent in prolactinomas, suggesting alternative mechanisms for tumor development.
    • Further research is needed, especially on surgically removed tumors, to elucidate the molecular pathogenesis of prolactinomas.